Skip to main content
OpenTrials
Completed

NCT Number: NCT05035043

Economic Burden of NAFLD

To determine the economic burden of NAFLD (Non-Alcoholic-Fatty-Liver Disease) patients in Belgium, Flanders by means of a bottom-up approach.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Non-Alcoholic Fatty Liver Disease Digestive System Diseases Fatty Liver Liver Diseases NAFLD

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hasselt University

Hasselt, 3500, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • having NAFLD as was diagnosed by FibroScan®,
  • 18 years or older
  • BMI ≥ 25 kg/m²

Exclusion criteria

  • unable to give informed consent
  • >70 years

Treatment and study plan

Determination of the economic burden NAFLD patients

Other

Determination of the economic burden NAFLD patients (Healthcare costs, patient costs, burden of disease

Primary outcomes

  1. iMTA MCQ

    Time frame: baseline

    Healthcare cost measured with the iMTA MCQ (Institute for Medical Technology Assessment Medical Consumption Questionnaire). The volumes of used healthcare costs were multiplied with the unit costs of these corresponding services.

Secondary outcomes

  1. iMTA MCQ

    Time frame: Baseline

    Patient cost measured with the iMTA MCQ (Institute for Medical Technology Assessment Medical Consumption Questionnaire). The volumes of used healthcare costs were multiplied with the unit costs of these corresponding services.

  2. EuroQol-5D-5L

    Time frame: baseline

    : Health related quality of life questionnaire EuroQol-5D-5L is used. Five levels are score in 5 dimensions. It is scaled from 0 to 100%. A higher score indicates a higher quality of life.

Sponsors and collaborators

Lead sponsor

Hasselt University

Other

Registry information

Official study title

The Economic Burden of Non-Alcoholic Fatty Liver Disease Patients in Flanders, Belgium

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Sep 5, 2021
Registry last updated
Dec 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.